Studies on the inhibitory effects of analogues of dapsone on neutrophil function in-vitro

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 1, 1997, Pages 53-57

  Coleman, Michael D ^a   Smith, Joanna K ^a,c   Perris, Alan D ^a   Buck, Nicola S ^a   Seydel, Joachim K ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4' AMINODIPHENYLSULFONE; 2 HYDROXY 4 PROPYLAMINO 5' AMINODIPHENYLSULFONE; 2 HYDROXY 4,4' AMINODIPHENYLSULFONE; 2 HYDROXYMETHYL 4' ETHYLAMINODIPHENYLSULFONE; 2 METHOXY 4 ETHYLAMINO 5' AMINODIPHENYLSULFONE; 2 METHYL 3 CYCLOPHENTYLAMINO 4' AMINODIPHENYLSULFONE; 2 METHYL 4 ACETYLAMINO 4' NITRODIPHENYLSULFONE; 2 METHYL 4,4' HEXYLAMINODIPHENYLSULFONE; 2 TRIFLUOROMETHYL 4 ETHYLAMINO 4' AMINODIPHENYLSULFONE; 2 TRIFLUOROMETHYL 4' AMINODIPHENYLSULFONE; 2,4 DIAMINO 5 [4 [3 (4'' AMINOPHENYL 4' SULFONYLPHENYLAMINO)PROPOXY] 3,5 DIMETHOXYBENZYL]PYRIMIDINE; ABDD1; ABDD39; ABDD5; AXDD16; AXDD17; DAPSONE; DAPSONE DERIVATIVE; INTERLEUKIN 1; K 130; N (4 AMINOBUTYL) 5 CHLORO 2 NAPSYLAMIDE; PXDD19; PXDD4; UNCLASSIFIED DRUG; W10; W25; WFC 1;

ADULT; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPOPHILICITY; NEUTROPHIL; NORMAL HUMAN; RESPIRATORY BURST; UMBILICAL VEIN;

EID: 0031027351     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06752.x     Document Type: Article

References (25)

1. Afford, S. C., Pongracz, J., Stockley, R. A., Crocker, J., Burnett, D. (1992) The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J. Biol. Chem. 267: 21612-21616
2. Booth, S. A., Moody, C. E., Dahl, M. V., Herron, M. J., Nelson, R. D. (1992) Dapsone suppresses integrin-mediated neutrophil adherence function. J. Invest. Dermatol. 98: 135-140
3. Coleman, M. D., Breckenridge, A. M., Park, B. K. (1989) Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. Br. J. Clin. Pharm. 28: 389-395
4. Coleman, M. D., Rhodes, L. A., Scott, A. K., Breckenridge, A. M., Park, B. K. (1992) The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br. J. Clin. Pharmacol. 34: 244-249
5. Coleman, M. D., Smith, S. N., Kelly, D. E., Kelly, S., Seydel, J. K. (1996) Studies on the toxicity of novel analogues of dapsone in-vitro using rat, human and heterologous metabolising systems. J. Pharm. Pharmacol. 48: 945-950
6. Debol, S. M., Herron, S. M., Nelson, R. D. (1995) Dapsone inhibits human neutrophil signal-transduction induced by chemoattractants. J. Invest. Dermatol. 104: 647
7. Elashoff, J. D. (1981) Down with multiple 't' tests. Gastroenterology 80: 615-619
8. Harvath, L., Yancy, K. B., Katz, S. I. (1986) Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulphones. J. Immunol. 137: 1305-1311
9. Junger, W. G., Cardoza, T. A., Liu, F. C., Hoyt, D. B., Goodwin, R. (1993) Improved rapid photometric assay for quantitative measurement of PMN migration. J. Immunol. Methods 160: 73-79
10. Kansy, M., Seydel, J. K., Wiese, M., Haller, R. (1992) Synthesis of new 2,4-diaminobenzylpyrimidines active against various bacterial species. Eur. J. Med. Chem. 27: 237-244
11. Kettle, A. J., Winterbourne, C. C. (1991) Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs. Biochem. Pharmacol. 41: 1485-1492
12. Kettle, A. J., Gedye, C. A., Winterbourn, C. C. (1993) Superoxide is an antagonist of anti-inflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase. Biochem. Pharmacol. 45: 2003-2010
13. Lawrence, M., Springer, T. (1991) Leukocytes roll on a selectin at physiological flow rates: distinction form and prerequisite for adhesion through integrins. Cell 65: 859-873
14. Manfredi, G., De Panfilis, G., Zampetti, M., Allegra, F. (1979) Studies on dapsone-induced haemolytic anaemia: methaemoglobin production and glucose-6-phosphate activity in correlation with dapsone dosage. Br. J. Dermatol. 100: 427-432
15. Moncrieff, J. (1994) Determination of dapsone in serum and saliva using reversed phase high performance liquid chromatography with ultraviolet or electrochemical detection. J. Chromatogr. 654: 103-110
16. Osborn, L. (1990) Leukocyte adhesion to endothelium in inflammation. Cell 62: 3-6
17. Pieper, H., Seydel, J. K., Kruger, G., Noll, K., Keck, J., Wiese, M. (1989) Preparation and biological activity of new substituted anti-malarial diaminodiphenylsulfones. Arzn. Forsch. 39: 1073-1080
18. Rhodes, L. E., Tingle, M. D., Park, B. K., Chu, P., Verbov, J. L., Friedmann P. S. (1995) Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Brit. J. Dermatol. 132: 257-262
19. Springer, T. A. (1990) Adhesion receptors of the immune system. Nature 346: 425-434
20. Thuong-Nguyen, V., Kadunce, D. P., Hendrix, J. D., Gammon, W. R., Zone, J. J. (1993) Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J. Invest. Dermatol. 100: 349-355
21. Uetrecht, J. P. (1992) The Role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab. Rev. 24: 299-366
22. Wozel, G., Lehmann, B. (1995) Dapsone inhibits the generation of 5-lipoxygenase products in human polymorphonuclear leukocytes. Skin Pharmacol. 8: 196-202
23. Zimmerman, B. J., Granger, D. N. (1994) Oxygen free radicals and the gastrointestinal tract-role in ischaemia-reperfusion injury. Hepato-Gastroenterology 41: 337-342
24. Zone, J. J. (1991) Dermatitis herpetiformis. Curr. Probl. Derm. 3: 4-42
25. van Zyl, J. M., Basson, K., Kriegler, A., van der Walt, B. J. (1991) Mechanisms by which clofazimine inhibits the myeloperoxidase system. Biochem. Pharmacol. 42: 599-608